Dose-dependent benefits of quercetin on tumorigenesis in the C3(1)/SV40Tag transgenic mouse model of breast cancer

References

• Freudenheim JL, Marshall JR, Vena JE, Laughlin R, Brasure JR, Swanson MK, et al. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst 1996; 88:340-8; PMID:8609642; http://dx.doi.org/10.1093/jnci/88.6.340
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Decarli A, Franceschi S, Gentile A, Negri E, Parazzini F. Dietary factors and the risk of breast cancer. Nutr Cancer 1987; 10:205-14; PMID:2829140; http://dx.doi.org/10.1080/01635588709513958
   PubMedGoogle Scholar
• Iscovich JM, Iscovich RB, Howe G, Shiboski S, Kaldor JM. A case-control study of diet and breast cancer in Argentina. Int J Cancer 1989; 44:770-6; PMID:2583858; http://dx.doi.org/10.1002/ijc.2910440504
   PubMed Web of Science ®Google Scholar
• Pawlega J. Breast cancer and smoking, vodka drinking and dietary habits. A case-control study. Acta Oncol 1992; 31:387-92; PMID:1632971; http://dx.doi.org/10.3109/02841869209088276
   PubMed Web of Science ®Google Scholar
• Butler LM, Wu AH, Wang R, Koh WP, Yuan JM, Yu MC. A vegetable-fruit-soy dietary pattern protects against breast cancer among postmenopausal Singapore Chinese women. Am J Clin Nutr 2010; 91:1013-9; PMID:20181808; http://dx.doi.org/10.3945/ajcn.2009.28572
   PubMed Web of Science ®Google Scholar
• Sangrajrang S, Chaiwerawattana A, Ploysawang P, Nooklang K, Jamsri P, Somharnwong S. Obesity, diet and physical inactivity and risk of breast cancer in Thai women. Asian Pac J Cancer Prev 2013; 14:7023-7; PMID:24377643; http://dx.doi.org/10.7314/APJCP.2013.14.11.7023
   PubMed Web of Science ®Google Scholar
• Kruk J. Association between Vegetable, Fruit and Carbohydrate Intake and Breast Cancer Risk in Relation to Physical Activity. Asian Pac J Cancer Prev 2014; 15:4429-36; PMID:24969864; http://dx.doi.org/10.7314/APJCP.2014.15.2.561
   PubMed Web of Science ®Google Scholar
• Gibellini L, Pinti M, Nasi M, Montagna JP, De Biasi S, Roat E, Bertoncelli L, Cooper EL, Cossarizza A. Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med 2011; 2011:591356; PMID:21792362; http://dx.doi.org/10.1093/ecam/neq053
   PubMed Web of Science ®Google Scholar
• Kobori M, Masumoto S, Akimoto Y, Oike H. Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57BL6J mice. Mol Nutr Food Res 2011; 55:530-40; PMID:21462320; http://dx.doi.org/10.1002/mnfr.201000392
   PubMed Web of Science ®Google Scholar
• Brusselmans K, Vrolix R, Verhoeven G, Swinnen JV. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. Journal of Biological Chemistry 2005; 280:5636-45; PMID:15533929; http://dx.doi.org/10.1074/jbc.M408177200
   PubMed Web of Science ®Google Scholar
• Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, Lee MT. The antitumor activities of flavonoids. In Vivo 2005; 19:895-909; PMID:16097445
   PubMed Web of Science ®Google Scholar
• Avila MA, Velasco JA, Cansado J, Notario V. Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res 1994; 54:2424-8; PMID:8162591
   PubMed Web of Science ®Google Scholar
• Choi EJ, Bae SM, Ahn WS. Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells. Arch Pharm Res 2008; 31:1281-5; PMID:18958418; http://dx.doi.org/10.1007/s12272-001-2107-0
   PubMed Web of Science ®Google Scholar
• Balabhadrapathruni S, Thomas TJ, Yurkow EJ, Amenta PS, Thomas T. Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cells. Oncol Rep 2000; 7:3-12; PMID:10601582
   PubMed Web of Science ®Google Scholar
• Conklin CM, Bechberger JF, MacFabe D, Guthrie N, Kurowska EM, Naus CC. Genistein and quercetin increase connexin43 and suppress growth of breast cancer cells. Carcinogenesis 2007; 28:93-100; PMID:16777995; http://dx.doi.org/10.1093/carcin/bgl106
   PubMed Web of Science ®Google Scholar
• Chien SY, Wu YC, Chung JG, Yang JS, Lu HF, Tsou MF, Wood WG, Kuo SJ, Chen DR. Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells. Hum Exp Toxicol 2009; 28:493-503; PMID:19755441; http://dx.doi.org/10.1177/0960327109107002
   PubMed Web of Science ®Google Scholar
• Seo HS, Ju JH, Jang K, Shin I. Induction of apoptotic cell death by phytoestrogens by up-regulating the levels of phospho-p53 and p21 in normal and malignant estrogen receptor alpha-negative breast cells. Nutr Res 2011; 31:139-46; PMID:21419318; http://dx.doi.org/10.1016/j.nutres.2011.01.011
   PubMed Web of Science ®Google Scholar
• Schlachterman A, Valle F, Wall KM, Azios NG, Castillo L, Morell L, Washington AV, Cubano LA, Dharmawardhane SF. Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl Oncol 2008; 1:19-27; PMID:18607509; http://dx.doi.org/10.1593/tlo.07100
   PubMed Web of Science ®Google Scholar
• So FV, Guthrie N, Chambers AF, Moussa M, Carroll KK. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer 1996; 26:167-81; PMID:8875554; http://dx.doi.org/10.1080/01635589609514473
   PubMed Web of Science ®Google Scholar
• Staedler D, Idrizi E, Kenzaoui BH, Juillerat-Jeanneret L. Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells. Cancer Chemother Pharmacol 2011; 68(5).
   Web of Science ®Google Scholar
• Verma AK, Johnson JA, Gould MN, Tanner MA. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res 1988; 48:5754-8; PMID:3139283
   PubMed Web of Science ®Google Scholar
• Zhong X, Wu K, He S, Ma S, Kong L. [Effects of quercetin on the proliferation and apoptosis in transplantation tumor of breast cancer in nude mice]. Sichuan Da Xue Xue Bao Yi Xue Ban 2003; 34:439-42; PMID:12910683
   PubMedGoogle Scholar
• Dechsupa S, Kothan S, Vergote J, Leger G, Martineau A, Berangeo S, Kosanlavit R, Moretti JL, Mankhetkorn S. Quercetin, Siamois 1 and Siamois 2 induce apoptosis in human breast cancer MDA-mB-435 cells xenograft in vivo. Cancer Biol Ther 2007; 6:56-61; PMID:17172819; http://dx.doi.org/10.4161/cbt.6.1.3548
   PubMed Web of Science ®Google Scholar
• Du G, Lin H, Yang Y, Zhang S, Wu X, Wang M, Ji L, Lu L, Yu L, Han G. Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice. Int Immunopharmacol 2010; 10:819-26; PMID:20447470; http://dx.doi.org/10.1016/j.intimp.2010.04.018
   PubMed Web of Science ®Google Scholar
• Green JE, Shibata MA, Yoshidome K, Liu ML, Jorcyk C, Anver MR, Wigginton J, Wiltrout R, Shibata E, Kaczmarczyk S, et al. The C3(1)SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene 2000; 19:1020-7; PMID:10713685; http://dx.doi.org/10.1038/sj.onc.1203280
   PubMed Web of Science ®Google Scholar
• Maroulakou IG, Anver M, Garrett L, Green JE. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc Natl Acad Sci U S A 1994; 91:11236-40; PMID:7972041; http://dx.doi.org/10.1073/pnas.91.23.11236
   PubMed Web of Science ®Google Scholar
• Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008; 22:659-61; PMID:17942826; http://dx.doi.org/10.1096/fj.07-9574LSF
   PubMed Web of Science ®Google Scholar
• Murphy EA, Davis JM, Barrilleaux TL, McClellan JL, Steiner JL, Carmichael MD, Pena MM, Hebert JR, Green JE. Benefits of exercise training on breast cancer progression and inflammation in C3(1)SV40Tag mice. Cytokine 2011; 55:274-9; PMID:21600785; http://dx.doi.org/10.1016/j.cyto.2011.04.007
   PubMed Web of Science ®Google Scholar
• Singh B, Mense SM, Bhat NK, Putty S, Guthiel WA, Remotti F, Bhat HK. Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats. Toxicol Appl Pharmacol 2010; 247:83-90; PMID:20600213; http://dx.doi.org/10.1016/j.taap.2010.06.011
   PubMed Web of Science ®Google Scholar
• Wong MY, Chiu GN. Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model. Nanomedicine 2011; 7(6).
   Web of Science ®Google Scholar
• Yoshidome K, Shibata MA, Couldrey C, Korach KS, Green JE. Estrogen promotes mammary tumor development in C3(1)SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression. Cancer Res 2000; 60:6901-10; PMID:11156389
   PubMed Web of Science ®Google Scholar
• Son TG, Camandola S, Mattson MP. Hormetic dietary phytochemicals. Neuromolecular Med 2008; 10:236-46; PMID:18543123; http://dx.doi.org/10.1007/s12017-008-8037-y
   PubMed Web of Science ®Google Scholar
• Metodiewa D, Jaiswal AK, Cenas N, Dickancaité E, Segura-Aguilar J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med 1999; 26:107-16; PMID:9890646; http://dx.doi.org/10.1016/S0891-5849(98)00167-1
   PubMed Web of Science ®Google Scholar
• Maher DM, Gupta BK, Nagata S, Jaggi M, Chauhan SC. Mucin 13: structure, function, and potential roles in cancer pathogenesis. Mol Cancer Res 2011; 9:531-7; PMID:21450906; http://dx.doi.org/10.1158/1541-7786.MCR-10-0443
   PubMed Web of Science ®Google Scholar
• Chauhan SC, Vannatta K, Ebeling MC, Vinayek N, Watanabe A, Pandey KK, Bell MC, Koch MD, Aburatani H, Lio Y, et al. Expression and functions of transmembrane mucin MUC13 in ovarian cancer. Cancer Res 2009; 69:765-74; PMID:19176398; http://dx.doi.org/10.1158/0008-5472.CAN-08-0587
   PubMed Web of Science ®Google Scholar
• Packer LM, Williams SJ, Callaghan S, Gotley DC, McGuckin MA. Expression of the cell surface mucin gene family in adenocarcinomas. Int J Oncol 2004; 25:1119-26; PMID:15375564
   PubMed Web of Science ®Google Scholar
• Walsh MD, Young JP, Leggett BA, Williams SH, Jass JR, McGuckin MA. The MUC13 cell surface mucin is highly expressed by human colorectal carcinomas. Hum Pathol 2007; 38:883-92; PMID:17360025; http://dx.doi.org/10.1016/j.humpath.2006.11.020
   PubMed Web of Science ®Google Scholar
• Shimamura T, Ito H, Shibahara J, Watanabe A, Hippo Y, Taniguchi H, Chen Y, Kashima T, Ohtomo T, Tanioka F, et al. Overexpression of MUC13 is associated with intestinal-type gastric cancer. Cancer Sci 2005; 96:265-73; PMID:15904467; http://dx.doi.org/10.1111/j.1349-7006.2005.00043.x
   PubMed Web of Science ®Google Scholar
• Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 2008; 14:1368-76; PMID:18316557; http://dx.doi.org/10.1158/1078-0432.CCR-07-1658
   PubMed Web of Science ®Google Scholar
• Bhalla A, Manjari M, Kahlon SK, Kumar P, Kalra N. Cytokeratin 56 expression in benign and malignant breast lesions. Indian J Pathol Microbiol 2010; 53:676-80; PMID:21045391; http://dx.doi.org/10.4103/0377-4929.72026
   PubMed Web of Science ®Google Scholar
• Cheng D, Kong H, Li Y. TMPRSS4 as a poor prognostic factor for triple-negative breast cancer. Int J Mol Sci 2013; 14:14659-68; PMID:23857060; http://dx.doi.org/10.3390/ijms140714659
   PubMed Web of Science ®Google Scholar
• Liang B, Wu M, Bu Y, Zhao A, Xie F. Prognostic value of TMPRSS4 expression in patients with breast cancer. Med Oncol 2013; 30:497; PMID:23420063; http://dx.doi.org/10.1007/s12032-013-0497-8
   PubMed Web of Science ®Google Scholar
• Reis-Filho JS, Steele D, Di Palma S, Jones RL, Savage K, James M, Milanezi F, Schmitt FC, Ashworth A. Distribution and significance of nerve growth factor receptor (NGFRp75NTR) in normal, benign and malignant breast tissue. Mod Pathol 2006; 19:307-19; PMID:16424897; http://dx.doi.org/10.1038/modpathol.3800542
   PubMed Web of Science ®Google Scholar
• Tsang JY, Wong KH, Lai MW, Lacambra MD, Ko CW, Chan SK, Lam CC, Yu AM, Tan PH, Tse GM. Nerve growth factor receptor (NGFR): a potential marker for specific molecular subtypes of breast cancer. J Clin Pathol 2013; 66:291-6; PMID:23268325; http://dx.doi.org/10.1136/jclinpath-2012-201027
   PubMed Web of Science ®Google Scholar
• Zhang H, Rakha EA, Ball GR, Spiteri I, Aleskandarany M, Paish EC,Powe DG, Macmillan RD, Caldas C, Ellis IO, et al. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer. Breast Cancer Res Treat 2010; 121:41-51; PMID:19590950; http://dx.doi.org/10.1007/s10549-009-0450-x
   PubMed Web of Science ®Google Scholar
• Alshareeda AT, Rakha EA, Nolan CC, Ellis IO, Green AR. Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer. Breast Cancer Res Treat 2012; 134:519-29; PMID:22562177; http://dx.doi.org/10.1007/s10549-012-2083-8
   PubMed Web of Science ®Google Scholar
• Tang XY, Umemura S, Tsukamoto H, Kumaki N, Tokuda Y, Osamura RY. Overexpression of fatty acid binding protein-7 correlates with basal-like subtype of breast cancer. Pathol Res Pract 2010; 206:98-101; PMID:19608352; http://dx.doi.org/10.1016/j.prp.2009.06.010
   PubMed Web of Science ®Google Scholar
• Wang M, Liu YE, Ni J, Aygun B, Goldberg ID, Shi YE. Induction of mammary differentiation by mammary-derived growth inhibitor-related gene that interacts with an omega-3 fatty acid on growth inhibition of breast cancer cells. Cancer Res 2000; 60:6482-7; PMID:11103817
   PubMed Web of Science ®Google Scholar
• Shi YE, Ni J, Xiao G, Liu YE, Fuchs A, Yu G, Su J, Cosgrove JM, Xing L, Zhang M, et al. Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG. Cancer Res 1997; 57:3084-91; PMID:9242429
   PubMed Web of Science ®Google Scholar
• Prat A, Adamo B, Cheang MC, Anders CK, Carey LA, Perou CM. Molecular characterization of basal-like and non-basal-like triple-negative breast cancer. Oncologist 2013; 18:123-33; PMID:23404817; http://dx.doi.org/10.1634/theoncologist.2012-0397
   PubMed Web of Science ®Google Scholar
• Riggins RB, Lan JP, Zhu Y, Klimach U, Zwart A, Cavalli LR, Haddad BR, Chen L, Gong T, Xuan J, et al. ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer. Cancer Res 2008; 68:8908-17; PMID:18974135; http://dx.doi.org/10.1158/0008-5472.CAN-08-2669
   PubMed Web of Science ®Google Scholar
• Ring A, Dowsett M. Mechanisms of tamoxifen resistance. Endocr Relat Cancer 2004; 11:643-58; PMID:15613444; http://dx.doi.org/10.1677/erc.1.00776
   PubMed Web of Science ®Google Scholar
• Hnatyszyn HJ, Liu M, Hilger A, Herbert L, Gomez-Fernandez CR, Jorda M, Thomas D, Rae JM, El-Ashry D, Lippman ME. Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody. Breast Cancer Res Treat 2010; 122:371-80; PMID:19842031; http://dx.doi.org/10.1007/s10549-009-0584-x
   PubMed Web of Science ®Google Scholar
• Rae JM, Johnson MD, Scheys JO, Cordero KE, Larios JM, Lippman ME. GREB 1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res Treat 2005; 92:141-9; PMID:15986123; http://dx.doi.org/10.1007/s10549-005-1483-4
   PubMed Web of Science ®Google Scholar
• Ghosh MG, Thompson DA, Weigel RJ. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res 2000; 60:6367-75; PMID:11103799
   PubMed Web of Science ®Google Scholar
• Sun J, Nawaz Z, Slingerland JM. Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen-responsive elements in breast cancer cells. Mol Endocrinol 2007; 21:2651-62; PMID:17666587; http://dx.doi.org/10.1210/me.2007-0082
   PubMed Web of Science ®Google Scholar
• Jordan NJ, Dutkowski CM, Barrow D, Mottram HJ, Hutcheson IR, Nicholson RI, Guichard SM, Gee JM. Impact of dual mTORC12 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro. Breast Cancer Res 2014; 16:R12; PMID:24457069; http://dx.doi.org/10.1186/bcr3604
   PubMed Web of Science ®Google Scholar
• Wang M, Liu YE, Greene J, Sheng S, Fuchs A, Rosen EM, Shi YE. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene 1997; 14:2767-74; PMID:9190892; http://dx.doi.org/10.1038/sj.onc.1201245
   PubMed Web of Science ®Google Scholar
• Davis JM, Murphy EA, Carmichael MD, Davis B. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol 2009; 296:R1071-7; PMID:19211721
   PubMed Web of Science ®Google Scholar
• Murphy EA, Davis JM, McClellan JL, Carmichael MD. Quercetin's effects on intestinal polyp multiplicity and macrophage number in the Apc(Min+) mouse. Nutr Cancer 2011; 63:421-6; PMID:21391122; http://dx.doi.org/10.1080/01635581.2011.535954
   PubMed Web of Science ®Google Scholar
• Shibata MA, Jorcyk CL, Liu ML, Yoshidome K, Gold LG, Green JE. The C3(1)SV40 T antigen transgenic mouse model of prostate and mammary cancer. Toxicol Pathol 1998; 26:177-82; PMID:9502400; http://dx.doi.org/10.1177/019262339802600121
   PubMed Web of Science ®Google Scholar
• Calvo A, Yokoyama Y, Smith LE, Ali I, Shih SC, Feldman AL, Libutti SK, Sundaram R, Green JE. Inhibition of the mammary carcinoma angiogenic switch in C3(1)SV40 transgenic mice by a mutated form of human endostatin. Int J Cancer 2002; 101:224-34; PMID:12209972; http://dx.doi.org/10.1002/ijc.10589
   PubMed Web of Science ®Google Scholar
• Steiner JL, Murphy EA, McClellan JL, Carmichael MD, Davis JM. Exercise training increases mitochondrial biogenesis in the brain. J Appl Physiol 2011; 111:1066-71; PMID:21817111; http://dx.doi.org/10.1152/japplphysiol.00343.2011
   PubMed Web of Science ®Google Scholar